What to Know About Devon Energy's $52.7 Million WaterBridge Stock Sale

Devon Energy has conducted a stock sale of WaterBridge valued at $52.7 million. Simultaneously, OrbiMed executed a $39 million sale of Enliven Therapeutics shares. This specific divestment by OrbiMed occurred during a period where Enliven Therapeutics experienced a 130% rally. Both transactions represent significant capital movements within their respective sectors, as reported in the financial data. These sales highlight strategic portfolio adjustments by the involved entities amidst varying market conditions and asset valuations.